Clinical Applications of Molecular Biomarkers in Prostate Cancer

Autor: Daniel E. Spratt, E. Almagro, Fernando López-Campos, Rebeca Lozano, Ignacio Rodríguez-Melcón, Guillermo Velasco, Ana Aurora Díaz-Gavela, Luis Miguel Quintana Franco, Elia del Cerro, Felipe Couñago, José López-Torrecilla, Alfonso Gomez-Iturriaga, Estefanía Linares Espinós, Esaú Fenández-Pascual, Iván Henríquez, Juan Ignacio Martínez-Salamanca, Luis Leonardo Guerrero

Publikováno v: DDFV: Repositorio Institucional de la Universidad Francisco de Vitoria
Universidad Francisco de Vitoria
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Cancers, Vol 12, Iss 1550, p 1550 (2020)
Cancers
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname

There is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological diversity has had only a minimal impact on clinical practice. Treatment outcomes in patients with localised PCa are often highly variable, even among p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec2eaa3c0d82484929164379c359014
http://hdl.handle.net/10641/2018